Next report date
Report period
Q1 2024
EPS estimate
−0.71USD
Revenue estimate
14.19 MUSD
−23.7052USD
−34.11 MUSD
50.29 MUSD
40.58 K
About Minerva Surgical, Inc.
Sector
Industry
CEO
Todd Usen
Website
Headquarters
Santa Clara
Employees (FY)
174
Founded
2008
FIGI
BBG012QFWLD6
Minerva Surgical, Inc. engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. It offers therapeutic devices for abnormal uterine bleeding treatment. The company was founded by Csaba Truckai in 2008 and is headquartered in Santa Clara, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of UTRS is 0.0010 USD — it has decreased by 99.76% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Minerva Surgical, Inc. stocks are traded under the ticker UTRS.
Minerva Surgical, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
UTRS stock is 40.90 K% volatile and has beta coefficient of −0.78. Check out the list of the most volatile stocks — is Minerva Surgical, Inc. there?
UTRS earnings for the last quarter are −0.81 USD per share, whereas the estimation was −1.00 USD resulting in a 19.00% surprise. The estimated earnings for the next quarter are −0.54 USD per share. See more details about Minerva Surgical, Inc. earnings.
Minerva Surgical, Inc. revenue for the last quarter amounts to 11.97 M USD despite the estimated figure of 13.21 M USD. In the next quarter revenue is expected to reach 13.93 M USD.
Yes, you can track Minerva Surgical, Inc. financials in yearly and quarterly reports right on TradingView.
UTRS stock has fallen by 99.80% compared to the previous week, the month change is a 99.82% fall, over the last year Minerva Surgical, Inc. has showed a 99.98% decrease.
UTRS net income for the last quarter is −7.18 M USD, while the quarter before that showed −8.68 M USD of net income which accounts for 17.28% change. Track more Minerva Surgical, Inc. financial stats to get the full picture.
Today Minerva Surgical, Inc. has the market capitalization of 443.93, it has decreased by 26.79% over the last week.
No, UTRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, UTRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Minerva Surgical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 174.00 employees. See our rating of the largest employees — is Minerva Surgical, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Minerva Surgical, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Minerva Surgical, Inc. stock shows the strong sell signal. See more of Minerva Surgical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Minerva Surgical, Inc. EBITDA is −25.35 M USD, and current EBITDA margin is −56.79%. See more stats in Minerva Surgical, Inc. financial statements.